Skip to main content
27 September, 2022

Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine

From October 5th to October 7th, Hyris will be present at the SIBioC 2022 in Genova, to present Hyris marketplace approach and Hyris SystemTM disruptive featuresfor laboratory medicine.

Our team will discuss with partners and prospects at Hyris stand First Floor, bar area.

  • Hyris signs a distribution agreement with GrowBIGogh

  • Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

  • Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

  • Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

  • Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

  • Hyris' new onboarding programs support researchers and developers to launch testing kits.

  • Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

  • Hyris and Singlabs signed a distributorship agreement for Singapore

  • Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

  • Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine